Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 2:03 pm Purchase |
2025-02-26 | 13G | LAVA Therapeutics N.V. LVTX |
BML Investment Partners, L.P. | 1,958,110 7.400% |
1,958,110 (New Position) |
Filing History |
| 2024-03-07 7:09 pm Sale |
2024-03-05 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 0 0.000% |
-1,878,194 (Position Closed) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,074,372 7.900% |
-741,824 (-26.34%) |
Filing History |
| 2023-11-09 4:37 pm Sale |
2023-11-03 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 1,878,194 7.100% |
-521,806 (-21.74%) |
Filing History |
| 2023-06-05 8:18 pm Sale |
2023-06-05 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 2,400,000 9.130% |
-670,558 (-21.84%) |
Filing History |
| 2023-02-24 4:38 pm Sale |
2023-02-22 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,070,558 11.700% |
-256,754 (-7.72%) |
Filing History |
| 2022-10-03 4:15 pm Unchanged |
2022-09-27 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 12.900% |
0 (Unchanged) |
Filing History |
| 2022-09-30 4:45 pm Unchanged |
2022-04-21 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 8.600% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,816,196 10.900% |
-8,213 (-0.29%) |
Filing History |
| 2021-04-08 4:31 pm Purchase |
2021-03-29 | 13D | LAVA Therapeutics N.V. LVTX |
Versant Venture Capital VI, L.P. | 3,407,157 13.400% |
3,407,157 (New Position) |
Filing History |
| 2021-04-08 4:11 pm Purchase |
2021-03-29 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,824,409 11.100% |
2,824,409 (New Position) |
Filing History |
| 2021-03-31 4:33 pm Purchase |
2021-03-24 | 13D | LAVA Therapeutics N.V. LVTX |
Novo Holdings A/S | 3,327,312 13.100% |
3,327,312 (New Position) |
Filing History |
| 2021-03-31 11:19 am Purchase |
2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX |
SANOFI SYNTHELABO SA | 1,919,455 7.000% |
1,919,455 (New Position) |
Filing History |
| 2021-03-31 08:27 am Purchase |
2021-03-26 | 13D | LAVA Therapeutics N.V. LVTX |
Cooperatieve Gilde Healthcare IV U.A. | 5,421,170 21.380% |
5,421,170 (New Position) |
Filing History |